Company Registration No. 13811971 (England and Wales)
SANSURE BIOTECH UK LTD
Unaudited accounts
for the period from 21 December 2021 to 31 December 2022
SANSURE BIOTECH UK LTD
Unaudited accounts
Contents
SANSURE BIOTECH UK LTD
Company Information
for the period from 21 December 2021 to 31 December 2022
Company Number
13811971 (England and Wales)
Registered Office
1-3 Pemberton Row
London
EC4A 3BG
SANSURE BIOTECH UK LTD
Statement of financial position
as at 31 December 2022
Cash at bank and in hand
2,125
Creditors: amounts falling due within one year
(5,362,816)
Net current liabilities
(5,105,524)
Called up share capital
500,000
Profit and loss account
(11,466)
Shareholders' funds
488,534
For the period ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 20 October 2023 and were signed on its behalf by
Yuxiang GONG
Director
Company Registration No. 13811971
SANSURE BIOTECH UK LTD
Notes to the Accounts
for the period from 21 December 2021 to 31 December 2022
SANSURE BIOTECH UK LTD is a private company, limited by shares, registered in England and Wales, registration number 13811971. The registered office is 1-3 Pemberton Row, London, EC4A 3BG.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Investments in shares are included at fair value if shares are publicly traded or their fair value can otherwise be measured reliably, otherwise investment in shares shall be measured at cost less impairment.
4
Investments
Other investments
Valuation at 21 December 2021
-
Valuation at 31 December 2022
5,594,058
Amounts falling due after more than one year
6
Creditors: amounts falling due within one year
2022
Bank loans and overdrafts
663
Amounts owed to group undertakings and other participating interests
5,361,193
SANSURE BIOTECH UK LTD
Notes to the Accounts
for the period from 21 December 2021 to 31 December 2022
7
Average number of employees
During the period the average number of employees was 0.